Immune and Neuroprotective Effects of Physical Activity on the Brain in Depression
Open accessThe DOI matches its Crossref record; 136 of the 136 references it cites were found in a registry or an index.
Abstract
Physical activity—a lifestyle factor that is associated with immune function, neuroprotection, and energy metabolism— modulates the cellular and molecular processes in the brain that are vital for emotional and cognitive health, collective mechanisms that can go awry in depression. Physical activity optimizes the stress response, neurotransmitter level and function (e.g., serotonergic, noradrenergic, dopaminergic, and glutamatergic), myokine production (e.g., interleukin-6), transcription factor levels and correlates (e.g., peroxisome proliferator-activated receptor C coactivator-1α [PGC-1α], mitochondrial density, nitric oxide pathway activity, Ca2+ signaling, reactive oxygen specie production, and AMP-activated protein kinase [AMPK] activity), kynurenine metabolites, glucose regulation, astrocytic health, and growth factors (e.g., brain-derived neurotrophic factor). Dysregulation of these interrelated processes can effectuate depression, a chronic mental illness that affects millions of individuals worldwide. Although the biogenic amine model has provided some clinical utility in understanding chronic depression, a need remains to better understand the interrelated mechanisms that contribute to immune dysfunction and the means by which various therapeutics mitigate them. Fortunately, convergent evidence suggests that physical activity improves emotional and cognitive function in persons with depression, particularly in those with comorbid inflammation. Accordingly, the aims of this review are to 1) underscore the link between inflammatory correlates and depression, 2) explicate immuno-neuroendocrine foundations, 3) elucidate evidence of neurotransmitter and cytokine crosstalk in depressive pathobiology, 4) determine the immunomodulatory effects of physical activity in depression, 5) examine protocols used to effectuate the positive effects of physical activity in depression, and 6) highlight implications for clinicians and scientists. It is our contention that a deeper understanding of the mechanisms by which inflammation contributes to the pathobiology of depression will translate to novel and more effective treatments, particularly by identifying relevant patient populations that can benefit from immune-based therapies within the context of personalized medicine.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
From inflammation to sickness and depression: when the immune system subjugates the brain
Dantzer, R., O'Connor, J. C., Freund, G. G., Johnson, R. W., & Kelley, K. W. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2297 · Cited by 7,395
Exercise training increases size of hippocampus and improves memory
Erickson, K. I., Voss, M. W., Prakash, R. S., Basak, C., Szabo, A., Chaddock, L., Kim, J. S., Heo, S., Alves, H., White, S. M., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1015950108 · Cited by 4,855
Adipokines in inflammation and metabolic disease
Ouchi, N., Parker, J. L., Lugus, J. J., & Walsh, K. (2011) · Nature Reviews Immunology · doi:10.1038/nri2921 · Cited by 4,625
Inflammation and Its Discontents: The Role of Cytokines in the Pathophysiology of Major Depression
Miller, A. H., Maletic, V., & Raison, C. L. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.11.029 · Cited by 3,848 · cited 3×
“, 2013), changes that correlate with depressivelike symptoms (Kenis and Maes, 2002; Tuglu et al., 2003; Basterzi et al., 2005; Tsao et al., 2006; Dantzer et al., 2008; Miller et al., 2009; Elgarf et al., 2014; Lu et al., 2017) but can be mitigated following antidepressant administration (Dantzer et al.”
BackgroundInfluentialAMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity
Cantó, C., Gerhart-Hines, Z., Feige, J. N., Lagouge, M., Noriega, L., Milne, J. C., Elliott, P. J., Puigserver, P., & Auwerx, J. (2009) · Nature · doi:10.1038/nature07813 · Cited by 3,300 · cited 1×
“PGC-1α activity is regulated after PA via translational modifications that include phosphorylation (Jäger et al., 2007), deacetylation (Cantó et al., 2009), and sumoylation (Rytinki and Palvimo, 2008), changes that enhance expression of target genes and PGC-1α itself.”
BackgroundFerrari, A. J., Charlson, F. J., Norman, R. E., Patten, S. B., Freedman, G., Murray, C. J. L., Vos, T., & Whiteford, H. A. (2013) · PLoS Medicine · doi:10.1371/journal.pmed.1001547 · Cited by 3,115
The anti-inflammatory effect of exercise
Petersen, A. M. W., & Pedersen, B. K. (2005) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00164.2004 · Cited by 3,100
Muscles, exercise and obesity: skeletal muscle as a secretory organ
Pedersen, B. K., & Febbraio, M. A. (2012) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2012.49 · Cited by 2,909
Kanda, H. (2006) · Journal of Clinical Investigation · doi:10.1172/jci26498 · Cited by 2,682
Getting formal with dopamine and reward
Schultz, W. (2002) · Neuron · doi:10.1016/s0896-6273(02)00967-4 · Cited by 2,574
AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1α
Jäger, S., Handschin, C., St.-Pierre, J., & Spiegelman, B. M. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0705070104 · Cited by 2,491 · cited 9×
“The up-regulation of PGC-1α putatively occurs following direct phosphorylation by activated AMPK (Jäger et al., 2007).”
BackgroundInfluentialGleeson, M., Bishop, N. C., Stensel, D. J., Lindley, M. R., Mastana, S. S., & Nimmo, M. A. (2011) · Nature Reviews Immunology · doi:10.1038/nri3041 · Cited by 2,470
Elenkov, I. J., Wilder, R. L., Chrousos, G. P., & Vizi, E. S. (2000) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01470-4 · Cited by 2,252
Inflammation: the link between insulin resistance, obesity and diabetes
Dandona, P. (2004) · Trends in Immunology · doi:10.1016/j.it.2003.10.013 · Cited by 2,170
Metabolic control through the PGC-1 family of transcription coactivators
Lin, J., Handschin, C., & Spiegelman, B. M. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.05.004 · Cited by 2,130 · cited 2×
“For example, PGC-1α coactivation of NRF1,2 elicits the expression of nuclear-encoded mitochondrial proteins and mitochondrial transcription factor A (Tfam) to stimulate mitochondrial DNA replication and transcription (Kelly et al., 2003; Puigserver and Spiegelman, 2003; Lin et al., 2005).”
BackgroundPuigserver, P., & Spiegelman, B. M. (2003) · Endocrine Reviews · doi:10.1210/er.2002-0012 · Cited by 2,076
The mesolimbic dopamine reward circuit in depression
Nestler, E. J., & Carlezon, W. A. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.09.018 · Cited by 2,059
Aston-Jones, G., & Bloom, F. (1981) · The Journal of Neuroscience · doi:10.1523/jneurosci.01-08-00876.1981 · Cited by 1,960
Patti, M. E., Butte, A. J., Crunkhorn, S., Cusi, K., Berria, R., Kashyap, S., Miyazaki, Y., Kohane, I., Costello, M., Saccone, R., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1032913100 · Cited by 1,952
Kern, P. A., Ranganathan, S., Li, C., Wood, L., & Ranganathan, G. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.280.5.e745 · Cited by 1,883 · cited 1×
“baseline IL-6 plasma levels are associated with obesity, insulin resistance, and Type-2 diabetes (Kern et al., 2001; Duncan et al., 2003; Dandona et al., 2004).”
BackgroundCooney, G. M., Dwan, K., Greig, C. A., Lawlor, D. A., Rimer, J., Waugh, F. R., McMurdo, M., & Mead, G. E. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004366.pub6 · Cited by 1,834
Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1
Yoon, J. C., Puigserver, P., Chen, G., Donovan, J., Wu, Z., Rhee, J., Adelmant, G., Stafford, J., Kahn, C. R., Granner, D. K., et al. (2001) · Nature · doi:10.1038/35093050 · Cited by 1,821
Extrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shut-off and cell death pathways
Hardingham, G. E., Fukunaga, Y., & Bading, H. (2002) · Nature Neuroscience · doi:10.1038/nn835 · Cited by 1,686 · cited 1×
“Quinolinic acid agonism of extrasynaptic NMDARs also inhibits the activity of cAMP response element binding (CREB) protein to block induction of BDNF gene expression (Hardingham et al., 2002).”
BackgroundTranscriptional paradigms in mammalian mitochondrial biogenesis and function
Scarpulla, R. C. (2008) · Physiological Reviews · doi:10.1152/physrev.00025.2007 · Cited by 1,666 · cited 2×
“…that enable cells modulate mitochondrial biogenesis, cellular respiration rates, and energy substrate uptake and utilization—changes that are particularly important for contractile and metabolic adaptations in skeletal muscle (Puigserver and Spiegelman, 2003; Wende et al., 2007; Scarpulla, 2008).”
BackgroundRaison, C. L., Rutherford, R. E., Woolwine, B. J., Shuo, C., Schettler, P., Drake, D. F., Haroon, E., & Miller, A. H. (2013) · JAMA Psychiatry · doi:10.1001/2013.jamapsychiatry.4 · Cited by 1,617 · cited 4×
“Others have shown that administration of anti-inflammatory agents in combination with antidepressants accelerates and enhances treatment response in a subset of persons with depression (Mendlewicz et al., 2006; Müller et al., 2006; Nery et al., 2008; Akhondzadeh et al., 2009; Abbasi et al., 2012; Raison et al., 2013).”
BackgroundResultInfluentialExercise as a treatment for depression: a meta-analysis adjusting for publication bias
Schuch, F. B., Vancampfort, D., Richards, J., Rosenbaum, S., Ward, P. B., & Stubbs, B. (2016) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2016.02.023 · Cited by 1,529 · cited 2×
“, 2013; Pemberton and Fuller Tyszkiewicz, 2016) in mild to moderate depression (Carek et al., 2011; Stanton and Reaburn, 2014; Kvam et al., 2016; Schuch et al., 2016) in all age groups (Abu-Omar et al.”
BackgroundInsulin-regulated hepatic gluconeogenesis through FOXO1–PGC-1α interaction
Puigserver, P., Rhee, J., Donovan, J., Walkey, C. J., Yoon, J. C., Oriente, F., Kitamura, Y., Altomonte, J., Dong, H., Accili, D., et al. (2003) · Nature · doi:10.1038/nature01667 · Cited by 1,487 · cited 1×
“…receptor (PPAR)γ (Puigserver and Spiegelman, 2003), PPARα (Vega et al., 2000), estrogen-related α (ERRα) (Huss et al., 2002), forkhead box O (FoxO) (Puigserver et al., 2003), hepatocyte nuclear factor 4α (HNF4α) (Yoon et al., 2001), and nuclear respiratory factors (NRFs) (Wu et al., 1999).”
BackgroundRelationship between Adipocyte Size and Adipokine Expression and Secretion
Skurk, T., Alberti-Huber, C., Herder, C., & Hauner, H. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1055 · Cited by 1,288 · cited 1×
“Low-grade inflammation putatively results when macrophages inundate white adipose tissue, liver, and skeletal muscle and elicit the persistent secretion of several types of “adipokines,” including the proinflammatory cytokines TNF-α, IL-1, IL-6, and monocyte chemoattractant protein-1 (MCP1) (Skurk et al., 2007).”
BackgroundThe Economic Burden of Depression in the United States: How Did It Change Between 1990 and 2000?
Greenberg, P. E., Kessler, R. C., Birnbaum, H. G., Leong, S. A., Lowe, S. W., Berglund, P. A., & Corey-Lisle, P. K. (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n1211 · Cited by 1,280 · cited 3×
“12:498. doi: 10.3389/fnins.2018.00498 Immune and Neuroprotective Effects of Physical Activity on the Brain in Depression Cristy Phillips 1,2* and Atoossa Fahimi 3 1 Physical Therapy, Arkansas State University, Jonesboro, AR, United States, 2 Physical Therapy, University of Tennessee Health Science Center, Memphis, TN,…”
BackgroundInfluentialPhasic Firing in Dopaminergic Neurons Is Sufficient for Behavioral Conditioning
Tsai, H.-C., Zhang, F., Adamantidis, A., Stuber, G. D., Bonci, A., de Lecea, L., & Deisseroth, K. (2009) · Science · doi:10.1126/science.1168878 · Cited by 1,266 · cited 1×
“Transient increases in phasic firing are thought to occur with exposure to unexpected rewards or aversive stimuli, thereby encoding a “reward prediction error” and reinforcing certain behaviors (Tsai et al., 2009).”
BackgroundThe role of dopamine in the pathophysiology of depression
Dunlop, B. W., & Nemeroff, C. B. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.3.327 · Cited by 1,244 · cited 1×
“, 2013), a cluster of symptoms that traditional SSRIs often fail to assuage (Dunlop and Nemeroff, 2007; Trivedi et al., 2008).”
BackgroundFerrari, A. J., Somerville, A. J., Baxter, A. J., Norman, R., Patten, S. B., Vos, T., & Whiteford, H. A. (2013) · Psychological Medicine · doi:10.1017/s0033291712001511 · Cited by 1,230
Vega, R. B., Huss, J. M., & Kelly, D. P. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.5.1868-1876.2000 · Cited by 1,195 · cited 2×
“The ability of PGC-1α to respond to changing metabolic needs during inflammation stems from its ability to selectively bind transcription factors, particularly peroxisome proliferatoractivated receptor (PPAR)γ (Puigserver and Spiegelman, 2003), PPARα (Vega et al., 2000), estrogen-related α (ERRα) (Huss et al., 2002),…”
BackgroundGoodpaster, B. H. (2001) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.12.5755 · Cited by 1,194 · cited 1×
“Paradoxically, endurance-trained athletes exhibit increased levels of intramuscular triglycerides and yet are highly insulin sensitive (Goodpaster et al., 2001).”
BackgroundGlial regulation of the cerebral microvasculature
Iadecola, C., & Nedergaard, M. (2007) · Nature Neuroscience · doi:10.1038/nn2003 · Cited by 1,153
Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment
Pariante, C. M., & Miller, A. H. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(00)01088-x · Cited by 1,147
Steensberg, A., van Hall, G., Osada, T., Sacchetti, M., Saltin, B., & Pedersen, B. K. (2000) · The Journal of Physiology · doi:10.1111/j.1469-7793.2000.00237.x · Cited by 1,095 · cited 2×
“, 2000), suggesting that IL-6 signals the liver to increase glucose output to regulate blood glucose concentration during times of energy need (Steensberg et al., 2000).”
BackgroundThe role of exercise and PGC1α in inflammation and chronic disease
Handschin, C., & Spiegelman, B. M. (2008) · Nature · doi:10.1038/nature07206 · Cited by 1,083
Dopamine neurons modulate neural encoding and expression of depression-related behaviour
Tye, K. M., Mirzabekov, J. J., Warden, M. R., Ferenczi, E. A., Tsai, H.-C., Finkelstein, J., Kim, S.-Y., Adhikari, A., Thompson, K. R., Andalman, A. S., et al. (2013) · Nature · doi:10.1038/nature11740 · Cited by 1,073 · cited 1×
“In contrast, decrements in dopaminergic neurotransmission can effectuate symptoms of impaired ability to experience pleasure (anhedonia), motivation, executive function, and motricity in persons with depression (Nestler and Carlezon, 2006; Tye et al., 2013), a cluster of symptoms that traditional SSRIs often fail to a…”
BackgroundTyring, S., Gottlieb, A., Papp, K., Gordon, K., Leonardi, C., Wang, A., Lalla, D., Woolley, M., Jahreis, A., Zitnik, R., et al. (2006) · The Lancet · doi:10.1016/s0140-6736(05)67763-x · Cited by 1,069 · cited 1×
“In persons with autoimmune or inflammatory disorders, tumor necrosis factor (TNF) antagonists and certain nonsteroidal antiinflammatory agents (Brunello et al., 2006; Müller et al., 2006; Tyring et al., 2006; Krishnan et al., 2007; Soczynska et al., 2009; Menter et al., 2010; Fond et al., 2014; Köhler et al., 2014; Ab…”
BackgroundExercise Treatment for Major Depression: Maintenance of Therapeutic Benefit at 10 Months
Babyak, M., Blumenthal, J. A., Herman, S., Khatri, P., Doraiswamy, M., Moore, K., Edward Craighead, W., Baldewicz, T. T., & Ranga Krishnan, K. (2000) · Psychosomatic Medicine · doi:10.1097/00006842-200009000-00006 · Cited by 1,063
Low-Grade Systemic Inflammation and the Development of Type 2 Diabetes
Duncan, B. B., Schmidt, M. I., Pankow, J. S., Ballantyne, C. M., Couper, D., Vigo, A., Hoogeveen, R., Folsom, A. R., & Heiss, G. (2003) · Diabetes · doi:10.2337/diabetes.52.7.1799 · Cited by 1,036
Long story short: the serotonin transporter in emotion regulation and social cognition
Canli, T., & Lesch, K.-P. (2007) · Nature Neuroscience · doi:10.1038/nn1964 · Cited by 1,034 · cited 1×
“This immense number of connections enable the raphe to modulate mood (Canli and Lesch, 2007), appetite (Blundell, 1984), arousal (Dubovsky, 1994), impulsivity (Dubovsky, 1994), aggression (Passamonti et al.”
BackgroundImmune function in sport and exercise
Gleeson, M. (2007) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00008.2007 · Cited by 1,016
Schindler, R., Mancilla, J., Endres, S., Ghorbani, R., Clark, S., & Dinarello, C. (1990) · Blood · doi:10.1182/blood.v75.1.40.40 · Cited by 1,012
BDNF and 5-HT: a dynamic duo in age-related neuronal plasticity and neurodegenerative disorders
Mattson, M. P., Maudsley, S., & Martin, B. (2004) · Trends in Neurosciences · doi:10.1016/j.tins.2004.08.001 · Cited by 942
Köhler, O., Benros, M. E., Nordentoft, M., Farkouh, M. E., Iyengar, R. L., Mors, O., & Krogh, J. (2014) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2014.1611 · Cited by 941
Cooney, G. M., Dwan, K., Greig, C. A., Lawlor, D. A., Rimer, J., Waugh, F. R., McMurdo, M., & Mead, G. E. (2014) · Advances in Psychiatric Treatment · doi:10.1192/apt.20.1.2 · Cited by 895
Exercise as a treatment for depression: A meta-analysis
Kvam, S., Kleppe, C. L., Nordhus, I. H., & Hovland, A. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.03.063 · Cited by 837
Leonard, B., & Maes, M. (2012) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2011.12.005 · Cited by 805
Exercise for the treatment of depression and anxiety
Carek, P. J., Laibstain, S. E., & Carek, S. M. (2011) · The International Journal of Psychiatry in Medicine · doi:10.2190/pm.41.1.c · Cited by 797
Müller, N., Schwarz, M. J., Dehning, S., Douhe, A., Cerovecki, A., Goldstein-Müller, B., Spellmann, I., Hetzel, G., Maino, K., Kleindienst, N., et al. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001805 · Cited by 794
Goshen, I., Kreisel, T., Ben-Menachem-Zidon, O., Licht, T., Weidenfeld, J., Ben-Hur, T., & Yirmiya, R. (2008) · Molecular Psychiatry · doi:10.1038/sj.mp.4002055 · Cited by 762
Agudelo, L. Z., Femenía, T., Orhan, F., Porsmyr-Palmertz, M., Goiny, M., Martinez-Redondo, V., Correia, J. C., Izadi, M., Bhat, M., Schuppe-Koistinen, I., et al. (2014) · Cell · doi:10.1016/j.cell.2014.07.051 · Cited by 739
Handschin, C., Rhee, J., Lin, J., Tarr, P. T., & Spiegelman, B. M. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1232352100 · Cited by 729
Regulation of mitochondrial biogenesis in skeletal muscle by CaMK
Wu, H., Kanatous, S. B., Thurmond, F. A., Gallardo, T., Isotani, E., Bassel-Duby, R., & Williams, R. S. (2002) · Science · doi:10.1126/science.1071163 · Cited by 684
D'Mello, C., Le, T., & Swain, M. G. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.3567-08.2009 · Cited by 675
Evidence that interleukin-6 is produced in human skeletal muscle during prolonged running
Ostrowski, K., Rohde, T., Zacho, M., Asp, S., & Pedersen, B. K. (1998) · The Journal of Physiology · doi:10.1111/j.1469-7793.1998.949bp.x · Cited by 673
Michael, L. F., Wu, Z., Cheatham, R. B., Puigserver, P., Adelmant, G., Lehman, J. J., Kelly, D. P., & Spiegelman, B. M. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.061035098 · Cited by 663 · cited 2×
“, 2003) and, in an autoregulatory manner, activates MEF2C andMEF2D (Michael et al., 2001; Lin et al., 2005).”
BackgroundDe Felice, F. G., Vieira, M. N. N., Bomfim, T. R., Decker, H., Velasco, P. T., Lambert, M. P., Viola, K. L., Zhao, W.-Q., Ferreira, S. T., & Klein, W. L. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0809158106 · Cited by 657 · cited 1×
“…circuit structure and function (via transmitter receptor trafficking), and plasticity (via alterations in synapse density) (Chiu et al., 2008), effects that may be particularly important in the aging hippocampus (Zhao et al., 2008; De Felice et al., 2009) given its importance for HPA regulation.”
BackgroundFelger, J. C., Li, Z., Haroon, E., Woolwine, B. J., Jung, M. Y., Hu, X., & Miller, A. H. (2016) · Molecular Psychiatry · doi:10.1038/mp.2015.168 · Cited by 620
Serotonin control of sleep-wake behavior
Monti, J. M. (2011) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2010.11.003 · Cited by 614 · cited 1×
“This immense number of connections enable the raphe to modulate mood (Canli and Lesch, 2007), appetite (Blundell, 1984), arousal (Dubovsky, 1994), impulsivity (Dubovsky, 1994), aggression (Passamonti et al., 2012), and the sleep-wake cycle (Monti, 2011).”
BackgroundCao, W., Daniel, K. W., Robidoux, J., Puigserver, P., Medvedev, A. V., Bai, X., Floering, L. M., Spiegelman, B. M., & Collins, S. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.7.3057-3067.2004 · Cited by 605
Inflammation-Induced Anhedonia: Endotoxin Reduces Ventral Striatum Responses to Reward
Eisenberger, N. I., Berkman, E. T., Inagaki, T. K., Rameson, L. T., Mashal, N. M., & Irwin, M. R. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.06.010 · Cited by 596 · cited 2×
“, 2014), recapitulating the effects of immune challenge (Eisenberger et al., 2010).”
BackgroundJelleyman, C., Yates, T., O'Donovan, G., Gray, L. J., King, J. A., Khunti, K., & Davies, M. J. (2015) · Obesity Reviews · doi:10.1111/obr.12317 · Cited by 588
Amyloid beta oligomers induce impairment of neuronal insulin receptors
Zhao, W., De Felice, F. G., Fernandez, S., Chen, H., Lambert, M. P., Quon, M. J., Krafft, G. A., & Klein, W. L. (2008) · The FASEB Journal · doi:10.1096/fj.06-7703com · Cited by 587
Depression and immune function
Kiecolt-Glaser, J. K., & Glaser, R. (2002) · Journal of Psychosomatic Research · doi:10.1016/s0022-3999(02)00309-4 · Cited by 571 · cited 1×
“Personalized prescriptions are particularly germane to the topic of depression as the condition is associated with increased morbidity and mortality (Kiecolt-Glaser and Glaser, 2002), and activation of the inflammatory response in persons with depression may engender”
BackgroundPGC-1α regulates the mitochondrial antioxidant defense system in vascular endothelial cells
VALLE, I., ALVAREZBARRIENTOS, A., ARZA, E., LAMAS, S., & MONSALVE, M. (2005) · Cardiovascular Research · doi:10.1016/j.cardiores.2005.01.026 · Cited by 556 · cited 1×
“PA also generates reactive oxygen species (ROS), which induces inflammatory cytokine production in skeletal muscle (Ji, 2008), an effect that can be mitigated by the upregulation of mitochondrial ROS-detoxifying enzymes via PGC-1α (St-Pierre et al., 2003; Valle et al., 2005).”
BackgroundCatecholamines and the Effects of Exercise, Training and Gender
Zouhal, H., Jacob, C., Delamarche, P., & Gratas-Delamarche, A. (2008) · Sports Medicine · doi:10.2165/00007256-200838050-00004 · Cited by 553
Maes, M. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.06.014 · Cited by 544 · cited 9×
“Finally, PA increases hippocampal neurotrophic factor levels (e.g., BDNF) to promote hippocampal health and, thereby, promotes stress hormone regulation (e.g., cortisol regulation). activated cell-mediated immunity with a T helper (Th)1-style response and elevated levels of IFN-γ (Maes et al., 1990; Maes, 2011), where…”
BackgroundInfluentialKynurenine pathway in major depression: Evidence of impaired neuroprotection
Myint, A.-M., Kim, Y. K., Verkerk, R., Scharpé, S., Steinbusch, H., & Leonard, B. (2007) · Journal of Affective Disorders · doi:10.1016/j.jad.2006.07.013 · Cited by 527
Blood lactate is an important energy source for the human brain.
van Hall, G., Stømstad, M., Rasmussen, P., Jans, Ø., Zaar, M., Gam, C., Quistorff, B., Secher, N. H., & Nielsen, H. B. (2009) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2009.35 · Cited by 522
Adaptive immunity in obesity and insulin resistance
Sell, H., Habich, C., & Eckel, J. (2012) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2012.114 · Cited by 486
Tarnopolsky, M. A., Rennie, C. D., Robertshaw, H. A., Fedak-Tarnopolsky, S. N., Devries, M. C., & Hamadeh, M. J. (2007) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00472.2006 · Cited by 457
Mead, G. E., Morley, W., Campbell, P., Greig, C. A., McMurdo, M., & Lawlor, D. A. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004366.pub4 · Cited by 448 · cited 1×
“Some reports suggest that PA outcomes compare favorably to antidepressant and cognitive behavioral therapy in mild to moderate depression (Mead et al., 2009).”
ResultCytokine-specific central monoamine alterations induced by interleukin-1, -2 and -6
Zalcman, S., Green-Johnson, J. M., Murray, L., Nance, D. M., Dyck, D., Anisman, H., & Greenberg, A. H. (1994) · Brain Research · doi:10.1016/0006-8993(94)90006-x · Cited by 439 · cited 1×
“Interestingly, some evidence suggests cytokine-specific alterations across brain regions: IL-1 and IL-2 administration increased dopamine turnover in the prefrontal cortex, whereas IL-6 increased turnover in the hippocampus and prefrontal cortex (Zalcman et al., 1994).”
BackgroundKohut, M. L., McCann, D. A., Russell, D. W., Konopka, D. N., Cunnick, J. E., Franke, W. D., Castillo, M. C., Reighard, A. E., & Vanderah, E. (2006) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2005.12.002 · Cited by 436 · cited 1×
“…levels are more readily maintained with chronic PA given that it reduces proinflammatory markers (e.g., IFN-γ and TNF-α) and increases anti-inflammatory markers (e.g., IL-6 and IL-10) (Petersen and Pedersen, 1985; Smith et al., 1999; Panagiotakos et al., 2005; Kohut et al., 2006; Liu et al., 2013).”
BackgroundImmune–neural connections: how the immune system’s response to infectious agents influences behavior
McCusker, R. H., & Kelley, K. W. (2013) · Journal of Experimental Biology · doi:10.1242/jeb.073411 · Cited by 429 · cited 1×
“By accessing the brain via the aforementioned mechanisms, systemic inflammation can activate resident microglia in the brain (McCusker and Kelley, 2013) following peripheral immune challenge (D’Mello et al.”
BackgroundChiu, S.-L., Chen, C.-M., & Cline, H. T. (2008) · Neuron · doi:10.1016/j.neuron.2008.04.014 · Cited by 425
Biological mechanisms underlying the role of physical fitness in health and resilience
Silverman, M. N., & Deuster, P. A. (2014) · Interface Focus · doi:10.1098/rsfs.2014.0040 · Cited by 416
Exercise, Antidepressant Medications, and Enhanced Brain Derived Neurotrophic Factor Expression
Russo-Neustadt, A. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00059-7 · Cited by 411
Exercise and the treatment of depression: A review of the exercise program variables
Stanton, R., & Reaburn, P. (2014) · Journal of Science and Medicine in Sport · doi:10.1016/j.jsams.2013.03.010 · Cited by 410 · cited 3×
“All five randomized controlled studies meeting inclusion criteria were aerobic in nature (walking on treadmill or outdoors, cycling on a stationary bike, or training on an elliptical machine) (Stanton and Reaburn, 2014).”
BackgroundGlutamate and Depression: Clinical and Preclinical Studies
PAUL, I. A., & SKOLNICK, P. (2003) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1300.016 · Cited by 408 · cited 2×
“Notwithstanding, extant therapeutics exert a slow pace of action (3–5weeks), have extensive side effects, and fail to provide full symptom relief in a significant proportion of persons treated (Paul and Skolnick, 2003; Trivedi, 2006).”
BackgroundLipid metabolism during endurance exercise
Horowitz, J. F., & Klein, S. (2000) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/72.2.558s · Cited by 397 · cited 1×
“, 2012) by catecholamineinduced elevations in lipolysis and non-esterified fatty acids that displace albumin-bound tryptophan (Horowitz and Klein, 2000).”
BackgroundAkhondzadeh, S., Jafari, S., Raisi, F., Nasehi, A. A., Ghoreishi, A., Salehi, B., Mohebbi-Rasa, S., Raznahan, M., & Kamalipour, A. (2009) · Depression and Anxiety · doi:10.1002/da.20589 · Cited by 397
Depression: The disorder and the burden
Reddy, M. S. (2010) · Indian Journal of Psychological Medicine · doi:10.4103/0253-7176.70510 · Cited by 392 · cited 2×
“Current estimates suggest that close to 300 million persons are affected worldwide (Ferrari et al., 2013a), making depression the leading cause of disability as measured by disability-adjusted life years (Reddy, 2010).”
BackgroundTuglu, C., Kara, S. H., Caliyurt, O., Vardar, E., & Abay, E. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1566-z · Cited by 391
Insulin signaling and insulin sensitivity after exercise in human skeletal muscle
Wojtaszewski, J. F., Hansen, B. F., Gade, Kiens, B., Markuns, J. F., Goodyear, L. J., & Richter, E. A. (2000) · Diabetes · doi:10.2337/diabetes.49.3.325 · Cited by 382
Th1, Th2, and Th3 cytokine alterations in major depression
MYINT, A., LEONARD, B., STEINBUSCH, H., & KIM, Y. (2005) · Journal of Affective Disorders · doi:10.1016/j.jad.2005.07.008 · Cited by 371 · cited 1×
“…evidence suggests an increased tendency for pro-inflammatory markers in persons with depression (increased interleukin [IL]-6, TNF-α, and CRP) relative to controls (Laske et al., 2008; Steiner et al., 2012), a trend that normalizes following response to antidepressants (Myint et al., 2005).”
BackgroundInfluentialBeneficial health effects of exercise – the role of IL-6 as a myokine
Pedersen, B. K., & Fischer, C. P. (2007) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2007.02.002 · Cited by 371
Effects of antidepressants on the production of cytokines
Kenis, G., & Maes, M. (2002) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145702003164 · Cited by 370 · cited 1×
“, 2013), changes that correlate with depressivelike symptoms (Kenis and Maes, 2002; Tuglu et al., 2003; Basterzi et al., 2005; Tsao et al., 2006; Dantzer et al., 2008; Miller et al., 2009; Elgarf et al., 2014; Lu et al., 2017) but can be mitigated following antidepressant administration (Dantzer et al.”
BackgroundAcute mental stress elicits delayed increases in circulating inflammatory cytokine levels
STEPTOE, A., WILLEMSEN, G., OWEN, N., FLOWER, L., & MOHAMED-ALI, V. (2001) · Clinical Science · doi:10.1042/cs1010185 · Cited by 354 · cited 1×
“helplessness, social defeat, and social isolation) induce proinflammatory cytokines centrally and peripherally (Steptoe et al., 2001; Bartolomucci et al., 2003; Grippo et al., 2005; Chourbaji et al., 2006; Audet et al., 2011; Gómez-Lázaro et al., 2011; Moller et al., 2013), changes that correlate with depressivelike s…”
BackgroundBacchi, E., Negri, C., Targher, G., Faccioli, N., Lanza, M., Zoppini, G., Zanolin, E., Schena, F., Bonora, E., & Moghetti, P. (2013) · Hepatology · doi:10.1002/hep.26393 · Cited by 350
Inflammation, Depression and Dementia: Are they Connected?
Leonard, B. E. (2007) · Neurochemical Research · doi:10.1007/s11064-007-9385-y · Cited by 342 · cited 2×
“Fascinatingly, parallel evidence demonstrates that a lack of physical activity (PA) promotes the accumulation of visceral fat, adipose infiltration by proinflammatory immune cells, persistent low-grade inflammation (Ouchi et al., 2011), and, thereby, an increased risk for depression (Leonard, 2007).”
BackgroundHandschin, C., Choi, C. S., Chin, S., Kim, S., Kawamori, D., Kurpad, A. J., Neubauer, N., Hu, J., Mootha, V. K., Kim, Y.-B., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31785 · Cited by 335 · cited 1×
“Interestingly, muscle tissue levels of TNF-α and IL-6 negatively correlate with PGC-1α levels in healthy and glucoseintolerant models (Handschin et al., 2007).”
BackgroundNeuroprotective effects of physical activity on the brain: a closer look at trophic factor signaling
Phillips, C., Baktir, M. A., Srivatsan, M., & Salehi, A. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00170 · Cited by 330
Self-citationTimmerman, K. L., Flynn, M. G., Coen, P. M., Markofski, M. M., & Pence, B. D. (2008) · Journal of Leukocyte Biology · doi:10.1189/jlb.0408244 · Cited by 324 · cited 1×
“Studies of human peripheral blood following PA demonstrate a reduction in circulating proinflammatory monocytes (Timmerman et al., 2008) and an increase in circulating regulatory T cells (Yeh et al.”
BackgroundAntidepressant effects of exercise: Evidence for an adult-neurogenesis hypothesis?
Ernst, C., Olson, A. K., Pinel, J. P. J., Lam, R. W., & Christie, B. R. (2006) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0610 · Cited by 322 · cited 1×
“Finally, the ability of PA to optimize levels of tryptophan and serotonin exerts positive effects on BDNF and neurogenesis in the prefrontal cortex and hippocampus, underscoring the interrelationship between these two signaling systems (Mattson et al., 2004; Ernst et al., 2006; Esch and Stefano, 2010).”
BackgroundCarbohydrate and the cytokine response to 2.5 h of running
Nehlsen-Cannarella, S. L., Fagoaga, O. R., Nieman, D. C., Henson, D. A., Butterworth, D. E., Schmitt, R. L., Bailey, E. M., Warren, B. J., Utter, A., & Davis, J. M. (1997) · Journal of Applied Physiology · doi:10.1152/jappl.1997.82.5.1662 · Cited by 311
Nery, F. G., Monkul, E. S., Hatch, J. P., Fonseca, M., Zunta‐Soares, G. B., Frey, B. N., Bowden, C. L., & Soares, J. C. (2008) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.912 · Cited by 298
Brain monoamines, exercise, and behavioral stress: animal models
DISHMAN, R. K. (1997) · Medicine & Science in Sports & Exercise · doi:10.1097/00005768-199701000-00010 · Cited by 291 · cited 1×
“Interestingly, most studies suggest that PA increases dopamine levels in several brain regions (Brown et al., 1979; de Castro and Duncan, 1985; Dishman, 1997; Meeusen et al., 1997; Soares et al., 1999).”
BackgroundInflammation, Glutamate, and Glia in Depression:A Literature Review
McNally, L., Bhagwagar, Z., & Hannestad, J. (2008) · CNS Spectrums · doi:10.1017/s1092852900016734 · Cited by 289 · cited 1×
“Within the brain, quinolinic acid is exclusively produced in microglial cells, intimating that microglial activation by proinflammatory cytokines may bias quinolinic acid production and facilitate NMDA agonism (Myint et al., 2007; McNally et al., 2008) along with astrocytic activation and apoptosis (Guillemin et al.”
BackgroundPhysical exercise and clinically depressed patients: a systematic review and meta-analysis
Silveira, H., Moraes, H., Oliveira, N., Coutinho, E. S. F., Laks, J., & Deslandes, A. (2013) · Neuropsychobiology · doi:10.1159/000345160 · Cited by 279 · cited 1×
“Another meta-analytic study by Silveira and colleagues demonstrated that aerobic PA moderately reduced the signs of depression, with populations over 60 years of age and those with mild depression deriving the greatest response (Silveira et al., 2013).”
BackgroundEffects of α‐AMPK knockout on exercise‐induced gene activation in mouse skeletal muscle
Jørgensen, S. B., Wojtaszewski, J. F. P., Viollet, B., Andreelli, F., Birk, J. B., Hellsten, Y., Schjerling, P., Vaulont, S., Neufer, P. D., Richter, E. A., et al. (2005) · The FASEB Journal · doi:10.1096/fj.04-3144fje · Cited by 274 · cited 1×
“PA also induces changes in AMP-activated protein kinase (AMPK), an energy sensor that becomes active when the AMP/ATP ratio is high (Jørgensen et al., 2005; Pedersen and Febbraio, 2012).”
BackgroundChronic Immune Stimulation Correlates with Reduced Phenylalanine Turnover
Neurauter, G., Schrocksnadel, K., Scholl-Burgi, S., Sperner-Unterweger, B., Schubert, C., Ledochowski, M., & Fuchs, D. (2008) · Current Drug Metabolism · doi:10.2174/138920008785821738 · Cited by 274
Gillen, J. B., Little, J. P., Punthakee, Z., Tarnopolsky, M. A., Riddell, M. C., & Gibala, M. J. (2012) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2012.01564.x · Cited by 272 · cited 1×
“Also, improvements in insulin signaling may persist for 24 h when the intensity is increased to near-maximal effort intermittently during trainings of shorter duration (20min) (Manders et al., 2010; Gillen et al., 2012), with some evidence suggesting that those with the highest baseline insulin resistance yield the gr…”
BackgroundNeuroplasticity of Dopamine Circuits After Exercise: Implications for Central Fatigue
Foley, T. E., & Fleshner, M. (2008) · NeuroMolecular Medicine · doi:10.1007/s12017-008-8032-3 · Cited by 261
A role for the transcriptional coactivator PGC-1α in muscle refueling.
Wende, A. R., Schaeffer, P. J., Parker, G. J., Zechner, C., Han, D.-H., Chen, M. M., Hancock, C. R., Lehman, J. J., Huss, J. M., McClain, D. A., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m707006200 · Cited by 257 · cited 1×
“…that enable cells modulate mitochondrial biogenesis, cellular respiration rates, and energy substrate uptake and utilization—changes that are particularly important for contractile and metabolic adaptations in skeletal muscle (Puigserver and Spiegelman, 2003; Wende et al., 2007; Scarpulla, 2008).”
BackgroundHaroon, E., Fleischer, C. C., Felger, J. C., Chen, X., Woolwine, B. J., Patel, T., Hu, X. P., & Miller, A. H. (2016) · Molecular Psychiatry · doi:10.1038/mp.2015.206 · Cited by 250
Lambert, C. P., Wright, N. R., Finck, B. N., & Villareal, D. T. (2008) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00006.2008 · Cited by 249 · cited 7×
“Within immune cells and skeletal muscles, PA decreases TLR4 and TLR2 expression (Gleeson, 1985; Lambert et al., 1985; Francaux, 2009), changes that decrease the inflammatory capacity of leukocytes and may alter whole-body chronic inflammation (Gleeson et al.”
BackgroundInfluentialCorticotropin-releasing hormone drives anandamide hydrolysis in the amygdala to promote anxiety
Gray, J. M., Vecchiarelli, H. A., Morena, M., Lee, T. T. Y., Hermanson, D. J., Kim, A. B., McLaughlin, R. J., Hassan, K. I., Kühne, C., Wotjak, C. T., et al. (2015) · The Journal of Neuroscience · doi:10.1523/jneurosci.2737-14.2015 · Cited by 246 · cited 1×
“, 2011a,b) and reduces stress-induced over excitability of the amygdala (Gray et al., 2015) in conditions of health.”
BackgroundThe many roads to mitochondrial dysfunction in neuroimmune and neuropsychiatric disorders
Morris, G., & Berk, M. (2015) · BMC Medicine · doi:10.1186/s12916-015-0310-y · Cited by 245 · cited 2×
“, 1986) via modulation of calcium levels (Goffer et al., 2013; Morris and Berk, 2015) and calcium/calmodulin-dependent activation of tyrosine hydroxylase (Greenwood et al.”
BackgroundMendlewicz, J., Kriwin, P., Oswald, P., Souery, D., Alboni, S., & Brunello, N. (2006) · International Clinical Psychopharmacology · doi:10.1097/00004850-200607000-00005 · Cited by 229 · cited 1×
“Others have shown that administration of anti-inflammatory agents in combination with antidepressants accelerates and enhances treatment response in a subset of persons with depression (Mendlewicz et al., 2006; Müller et al., 2006; Nery et al., 2008; Akhondzadeh et al., 2009; Abbasi et al., 2012; Raison et al., 2013).”
BackgroundBufalino, C., Hepgul, N., Aguglia, E., & Pariante, C. M. (2013) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2012.04.009 · Cited by 228 · cited 1×
“Certain polymorphisms in genes associated with inflammation are associated with the risk for the development of mood disorders and treatment response (Bufalino et al., 2013; Michopoulos et al., 2015).”
BackgroundCytokines, prostaglandins and nitric oxide in the regulation of stress-response systems
Gądek-Michalska, A., Tadeusz, J., Rachwalska, P., & Bugajski, J. (2013) · Pharmacological Reports · doi:10.1016/s1734-1140(13)71527-5 · Cited by 225 · cited 2×
“The latter occurs via dense noradrenergic projections from the LC to corticotropin-releasing hormones in the paraventricular nucleus of the hypothalamus, enabling psychological stress and immune challenges to activate the hypothalamus and trigger glucocorticoid release (Gadek-Michalska et al., 2013).”
BackgroundPedersen, B. K., Steensberg, A., & Schjerling, P. (2001) · Current Opinion in Hematology · doi:10.1097/00062752-200105000-00002 · Cited by 223
Mori, K., Ozaki, E., Zhang, B., Yang, L., Yokoyama, A., Takeda, I., Maeda, N., Sakanaka, M., & Tanaka, J. (2002) · Neuropharmacology · doi:10.1016/s0028-3908(02)00211-3 · Cited by 215 · cited 1×
“The maintenance of basal levels of noradrenaline is important for inhibiting the release of the proinflammatory cytokines by microglia (Feinstein et al., 2002; Mori et al., 2002) and stimulating astrocytes to release trophic factors (e.g., BDNF) for neuroprotection (Junker et al., 2002).”
BackgroundEffect of Lipopolysaccharide on Inflammation and Insulin Action in Human Muscle
Liang, H., Hussey, S. E., Sanchez-Avila, A., Tantiwong, P., & Musi, N. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063983 · Cited by 215
Felger, J. C., Mun, J., Kimmel, H. L., Nye, J. A., Drake, D. F., Hernandez, C. R., Freeman, A. A., Rye, D. B., Goodman, M. M., Howell, L. L., et al. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.115 · Cited by 214 · cited 2×
“In fact, patients treated with IFN-α demonstrate reduced BH4 function in the brain (Felger et al., 2013a).”
BackgroundMichopoulos, V., Rothbaum, A. O., Jovanovic, T., Almli, L. M., Bradley, B., Rothbaum, B. O., Gillespie, C. F., & Ressler, K. J. (2015) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2014.14020263 · Cited by 203 · cited 1×
“Certain polymorphisms in genes associated with inflammation are associated with the risk for the development of mood disorders and treatment response (Bufalino et al., 2013; Michopoulos et al., 2015).”
BackgroundPhysiology of psychoneuroimmunology: A personal view
Besedovsky, H. O., & Rey, A. D. (2007) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2006.09.008 · Cited by 202 · cited 3×
“, 1997) at the level of the hypothalamus and anterior pituitary (Besedovsky and Rey, 2007).”
Starkie, R. L., Arkinstall, M. J., Koukoulas, I., Hawley, J. A., & Febbraio, M. A. (2001) · The Journal of Physiology · doi:10.1111/j.1469-7793.2001.0585a.x · Cited by 197 · cited 4×
“Other work shows that IL-6 can increase up to 100-fold with prolonged PA (Fischer, 2006), a trend that was attenuated with carbohydrate ingestion during PA (Nehlsen-Cannarella et al., 1985; Starkie et al., 2001) and pre-exercise glycogen depletion (50”
BackgroundInfluentialEisele, P. S., Salatino, S., Sobek, J., Hottiger, M. O., & Handschin, C. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.375253 · Cited by 187 · cited 1×
“The NF-κB pathway contributes to cytokine production and cell survival (Eisele et al., 2013).”
BackgroundLow-Intensity Exercise Reduces the Prevalence of Hyperglycemia in Type 2 Diabetes
MANDERS, R. J. F., VAN DIJK, J.-W. M., & VAN LOON, L. J. C. (2010) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0b013e3181b3b16d · Cited by 180 · cited 1×
“Also, improvements in insulin signaling may persist for 24 h when the intensity is increased to near-maximal effort intermittently during trainings of shorter duration (20min) (Manders et al., 2010; Gillen et al., 2012), with some evidence suggesting that those with the highest baseline insulin resistance yield the gr…”
BackgroundFelger, J. C., Li, L., Marvar, P. J., Woolwine, B. J., Harrison, D. G., Raison, C. L., & Miller, A. H. (2013) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2012.10.010 · Cited by 176
Kohman, R. A., DeYoung, E. K., Bhattacharya, T. K., Peterson, L. N., & Rhodes, J. S. (2012) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2011.10.006 · Cited by 176
Lu, Y., Ho, C. S., Liu, X., Chua, A. N., Wang, W., McIntyre, R. S., & Ho, R. C. (2017) · PLOS ONE · doi:10.1371/journal.pone.0186700 · Cited by 164 · cited 2×
“, 2013), changes that correlate with depressivelike symptoms (Kenis and Maes, 2002; Tuglu et al., 2003; Basterzi et al., 2005; Tsao et al., 2006; Dantzer et al., 2008; Miller et al., 2009; Elgarf et al., 2014; Lu et al., 2017) but can be mitigated following antidepressant administration (Dantzer et al.”
BackgroundInfluentialClinical Evidence and Potential Neurobiological Underpinnings of Unresolved Symptoms of Depression
Trivedi, M. H., Hollander, E., Nutt, D., & Blier, P. (2008) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v69n0211 · Cited by 153
Guo, J.-Y., Li, C.-Y., Ruan, Y.-P., Sun, M., Qi, X.-L., Zhao, B.-S., & Luo, F. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.03.076 · Cited by 148 · cited 2×
“, 2017) but can be mitigated following antidepressant administration (Dantzer et al., 2008; Guo et al., 2009; Miller et al., 2009; Elgarf et al., 2014; Lu et al., 2017).”
BackgroundInfluentialBrockett, A. T., LaMarca, E. A., & Gould, E. (2015) · PLoS ONE · doi:10.1371/journal.pone.0124859 · Cited by 142 · cited 1×
“Others have shown that PA induces an increase in astrocyte cell body area and number of contacts between astrocytic endfeet and blood vessels in the hippocampus, medial prefrontal cortex, and orbitofrontal cortex (Brockett et al., 2015).”
BackgroundAbbott, R., Whear, R., Nikolaou, V., Bethel, A., Coon, J. T., Stein, K., & Dickens, C. (2015) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2015.04.008 · Cited by 121 · cited 1×
“…factor (TNF) antagonists and certain nonsteroidal antiinflammatory agents (Brunello et al., 2006; Müller et al., 2006; Tyring et al., 2006; Krishnan et al., 2007; Soczynska et al., 2009; Menter et al., 2010; Fond et al., 2014; Köhler et al., 2014; Abbott et al., 2015) exert antidepressant effects.”
BackgroundShibakawa, Y. S., Sasaki, Y., Goshima, Y., Echigo, N., Kamiya, Y., Kurahashi, K., Yamada, Y., & Andoh, T. (2005) · British Journal of Anaesthesia · doi:10.1093/bja/aei256 · Cited by 96 · cited 1×
“Interestingly, the NMDA antagonist ketamine decreased lipopolysaccharide-induced TNF-α production in astrocyte and microglial cultures (Shibakawa et al., 2005).”
BackgroundFahimi, A., Baktir, M. A., Moghadam, S., Mojabi, F. S., Sumanth, K., McNerney, M. W., Ponnusamy, R., & Salehi, A. (2017) · Brain Structure and Function · doi:10.1007/s00429-016-1308-8 · Cited by 94
Self-citationde Castro, J. M., & Duncan, G. (1985) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(85)90407-1 · Cited by 73
PGC-1α and Myokines in the Aging Muscle – A Mini-Review
Arnold, A.-S., Egger, A., & Handschin, C. (2011) · Gerontology · doi:10.1159/000281883 · Cited by 65 · cited 1×
“Transgenic studies of PGC1α in rodents suggest the factor modulates local and systemic inflammation, including levels of TNF-α and IL-6 (Handschin and Spiegelman, 2008; Handschin, 2009; Arnold et al., 2011).”
BackgroundFornaro, M., Rocchi, G., Escelsior, A., Contini, P., & Martino, M. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.08.007 · Cited by 59 · cited 1×
“, 1990; Maes, 2011), whereas others exhibit a distinct subtype wherein a Th2-style response predominates (Fornaro et al., 2013), possibly reflective of different stressor profiles, disease points, or genetic contributions.”
Background
Cited by
Billot, M., Calvani, R., Urtamo, A., Sánchez-Sánchez, J. L., Ciccolari-Micaldi, C., Chang, M., Roller-Wirnsberger, R., Wirnsberger, G., Sinclair, A., Vaquero-Pinto, M. N., et al. (2020) · Clinical Interventions in Aging · doi:10.2147/cia.s253535 · Cited by 242
“There is increasing evidence that low physical activity levels increases the accumulation of visceral fat, adipose infiltration by pro-inflammatory immune cells and persistent low-grade inflammation.(116) In his review article Philipps(117) provided evidence that long-term physical activity modulates age-related cellu…”
BackgroundPhysical Exercise and Neuroinflammation in Major Depressive Disorder
Ignácio, Z. M., da Silva, R. S., Plissari, M. E., Quevedo, J., & Réus, G. Z. (2019) · Molecular Neurobiology · doi:10.1007/s12035-019-01670-1 · Cited by 153
Javelle, F., Laborde, S., Hosang, T. J., Metcalfe, A. J., & Zimmer, P. (2021) · Frontiers in Psychology · doi:10.3389/fpsyg.2021.623946 · Cited by 25
“, 2018), improved immune function (Phillips and Fahimi, 2018; Rumpf et al., 2021), and decreased permeability of the blood–brain barrier (Małkiewicz et al.”
Background
Metadata
- Authors
- Phillips, C., & Fahimi, A.
- Venue
- Frontiers in Neuroscience
- Publisher
- Frontiers Media SA
- Published
- 2018-07-26
- Volume
- 12
- Pages
- 498-498
- ISSN
- 1662-453X (ISSN-L)
- OpenAlex
- W2817244928
- Cited by
- 81
- References
- 136
- FWCI
- 1.89
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.